Thermo Fisher Scientific Launches Organ Transplant Matching Advancements During ASHI 2021

Press Release

Announced at ASHI was a rapid next-generation sequencing (NGS) assay that will provide high-resolution data in five hours

(ASHI 2021) ORLANDO, Fla., Sept. 30, 2021 — At the annual meeting for the American Society for Histocompatibility and Immunogenetics (ASHI) this week, Thermo Fisher Scientific announced two new additions to its transplant diagnostics portfolio. These new products will enable transplant laboratories to better characterize samples and bring speed and confidence to the transplant laboratory. More than 100,000 adults are now on a waiting list for a kidney and 7,500 more await a donated heart, highlighting the need for new technologies that enable better, faster donor–recipient matching.

"This new reagent may enable us to identify specific reactivity with greater clarity, improving our ability to determine immunologic risk at all stages of the transplant patient journey."

Sam Ho | Director, Histocompatibility and Infectious Disease Testing Laboratory, Gift of Hope Organ & Tissue Donor Network

Read full Press Release

Share This Page

Media Contact

Deborah Bright

Phone: 619-513-6612